FDA

Appeals Court Restricts Access to Abortion Pill Mifepristone

News Desk2 days ago2 days ago03 mins

A federal appeals court in New Orleans has issued a ruling that significantly restricts access to mifepristone, a primary medication used for abortion in the United States, by prohibiting the distribution of the drug via mail. The decision, handed down by the U.S. Court of Appeals for the Fifth Circuit, mandates that the medication must…

FDA Expands Access to Breakthrough Pancreatic Cancer Therapy

News Desk2 days ago2 days ago03 mins

Expanding Treatment Frontiers The U.S. Food and Drug Administration (FDA) has officially expanded access to daraxonrasib, a novel therapeutic agent designed to treat advanced pancreatic cancer. The agency’s decision, announced this week in Washington, D.C., follows compelling clinical data demonstrating the drug’s efficacy in patients who have exhausted traditional chemotherapy options. Former U.S. Senator Ben…